Cargando…

A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy

BACKGROUND & OBJECTIVES: Angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) have been used to normalize the blood pressure and the dipping pattern in patients with type 1 diabetes mellitus (T1DM) and nephropathy. However, there are no data on the effect of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Anantharaman, R., Bhansali, Anil, Bhadada, Sanjay K., Kohli, Harbir S., Walia, Rama, Shanmugasundar, G., Jayaprakash, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249964/
https://www.ncbi.nlm.nih.gov/pubmed/22199105
http://dx.doi.org/10.4103/0971-5916.90991
_version_ 1782220421014224896
author Anantharaman, R.
Bhansali, Anil
Bhadada, Sanjay K.
Kohli, Harbir S.
Walia, Rama
Shanmugasundar, G.
Jayaprakash, P.
author_facet Anantharaman, R.
Bhansali, Anil
Bhadada, Sanjay K.
Kohli, Harbir S.
Walia, Rama
Shanmugasundar, G.
Jayaprakash, P.
author_sort Anantharaman, R.
collection PubMed
description BACKGROUND & OBJECTIVES: Angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) have been used to normalize the blood pressure and the dipping pattern in patients with type 1 diabetes mellitus (T1DM) and nephropathy. However, there are no data on the effect of the dual blockade on the dipping pattern in these subjects. We therefore, carried out this study to evaluate the effect of administrating an ACEI followed by ARB in the optimum doses in T1DM patients with nephropathy on 24 h blood pressure (BP) profile and nocturnal dipping pattern. METHODS: An open label interventional pilot study was done during a one year period involving 30 consecutive patients who were treated with telmisartan 80 mg (0800-1000 h) for eight weeks followed by addition of ramipril 10 mg (1200-1400 h) for the next eight weeks. Ambulatory BP, dipping pattern and albumin excretion rate were studied after each phase. Twenty patients were hypertensive and 10 patients had macro- and 20 patients had microalbuminuria. RESULTS: Telmisartan produced a fall in the clinic BP by 4/1.3 mm Hg (P<0.05 and P<0.362, respectively), 2/1.9 mm Hg in the mean 24 h BP, 1.4/1.1 mm Hg in the day BP and 3.7/3 mm Hg in the trough BP. Addition of ramipril to telmisartan produced a further reduction of 6.3/5.9 mm Hg in the clinic BP (P<0.001 for both), 4.3/4.2 mm Hg in the mean 24 h BP (P<0.01 and P<0.0001, respectively), 5.8/3.9 mm Hg in the day BP (P<0.01 for both), 4.2/2.5 mm Hg in the trough BP, with a reduction of clinic SBP and DBP of 10.3/7.2 mm Hg from the baseline. Telmisartan restored normal systolic dipping pattern in 33.3 per cent of the nondippers (P<0.01) but addition of ramipril was not complimentary. Hyperkalamia (>5.5 mmol/l) was observed only in 2 patients towards the end of the study. INTERPRETATION & CONCLUSIONS: The dual blockade with telmisartan and ramipril had complimentary effect on lowering of the BP, however, similar beneficial effect on the nocturnal dipping was not observed. Further studies with large number of subjects with longer duration of follow-up are required to validate these observations.
format Online
Article
Text
id pubmed-3249964
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-32499642012-01-05 A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy Anantharaman, R. Bhansali, Anil Bhadada, Sanjay K. Kohli, Harbir S. Walia, Rama Shanmugasundar, G. Jayaprakash, P. Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Angiotensin converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) have been used to normalize the blood pressure and the dipping pattern in patients with type 1 diabetes mellitus (T1DM) and nephropathy. However, there are no data on the effect of the dual blockade on the dipping pattern in these subjects. We therefore, carried out this study to evaluate the effect of administrating an ACEI followed by ARB in the optimum doses in T1DM patients with nephropathy on 24 h blood pressure (BP) profile and nocturnal dipping pattern. METHODS: An open label interventional pilot study was done during a one year period involving 30 consecutive patients who were treated with telmisartan 80 mg (0800-1000 h) for eight weeks followed by addition of ramipril 10 mg (1200-1400 h) for the next eight weeks. Ambulatory BP, dipping pattern and albumin excretion rate were studied after each phase. Twenty patients were hypertensive and 10 patients had macro- and 20 patients had microalbuminuria. RESULTS: Telmisartan produced a fall in the clinic BP by 4/1.3 mm Hg (P<0.05 and P<0.362, respectively), 2/1.9 mm Hg in the mean 24 h BP, 1.4/1.1 mm Hg in the day BP and 3.7/3 mm Hg in the trough BP. Addition of ramipril to telmisartan produced a further reduction of 6.3/5.9 mm Hg in the clinic BP (P<0.001 for both), 4.3/4.2 mm Hg in the mean 24 h BP (P<0.01 and P<0.0001, respectively), 5.8/3.9 mm Hg in the day BP (P<0.01 for both), 4.2/2.5 mm Hg in the trough BP, with a reduction of clinic SBP and DBP of 10.3/7.2 mm Hg from the baseline. Telmisartan restored normal systolic dipping pattern in 33.3 per cent of the nondippers (P<0.01) but addition of ramipril was not complimentary. Hyperkalamia (>5.5 mmol/l) was observed only in 2 patients towards the end of the study. INTERPRETATION & CONCLUSIONS: The dual blockade with telmisartan and ramipril had complimentary effect on lowering of the BP, however, similar beneficial effect on the nocturnal dipping was not observed. Further studies with large number of subjects with longer duration of follow-up are required to validate these observations. Medknow Publications & Media Pvt Ltd 2011-11 /pmc/articles/PMC3249964/ /pubmed/22199105 http://dx.doi.org/10.4103/0971-5916.90991 Text en Copyright: © The Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Anantharaman, R.
Bhansali, Anil
Bhadada, Sanjay K.
Kohli, Harbir S.
Walia, Rama
Shanmugasundar, G.
Jayaprakash, P.
A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy
title A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy
title_full A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy
title_fullStr A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy
title_full_unstemmed A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy
title_short A pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy
title_sort pilot study on the effect of telmisartan & ramipril on 24 h blood pressure profile & dipping pattern in type 1 diabetes patients with nephropathy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249964/
https://www.ncbi.nlm.nih.gov/pubmed/22199105
http://dx.doi.org/10.4103/0971-5916.90991
work_keys_str_mv AT anantharamanr apilotstudyontheeffectoftelmisartanramiprilon24hbloodpressureprofiledippingpatternintype1diabetespatientswithnephropathy
AT bhansalianil apilotstudyontheeffectoftelmisartanramiprilon24hbloodpressureprofiledippingpatternintype1diabetespatientswithnephropathy
AT bhadadasanjayk apilotstudyontheeffectoftelmisartanramiprilon24hbloodpressureprofiledippingpatternintype1diabetespatientswithnephropathy
AT kohliharbirs apilotstudyontheeffectoftelmisartanramiprilon24hbloodpressureprofiledippingpatternintype1diabetespatientswithnephropathy
AT waliarama apilotstudyontheeffectoftelmisartanramiprilon24hbloodpressureprofiledippingpatternintype1diabetespatientswithnephropathy
AT shanmugasundarg apilotstudyontheeffectoftelmisartanramiprilon24hbloodpressureprofiledippingpatternintype1diabetespatientswithnephropathy
AT jayaprakashp apilotstudyontheeffectoftelmisartanramiprilon24hbloodpressureprofiledippingpatternintype1diabetespatientswithnephropathy
AT anantharamanr pilotstudyontheeffectoftelmisartanramiprilon24hbloodpressureprofiledippingpatternintype1diabetespatientswithnephropathy
AT bhansalianil pilotstudyontheeffectoftelmisartanramiprilon24hbloodpressureprofiledippingpatternintype1diabetespatientswithnephropathy
AT bhadadasanjayk pilotstudyontheeffectoftelmisartanramiprilon24hbloodpressureprofiledippingpatternintype1diabetespatientswithnephropathy
AT kohliharbirs pilotstudyontheeffectoftelmisartanramiprilon24hbloodpressureprofiledippingpatternintype1diabetespatientswithnephropathy
AT waliarama pilotstudyontheeffectoftelmisartanramiprilon24hbloodpressureprofiledippingpatternintype1diabetespatientswithnephropathy
AT shanmugasundarg pilotstudyontheeffectoftelmisartanramiprilon24hbloodpressureprofiledippingpatternintype1diabetespatientswithnephropathy
AT jayaprakashp pilotstudyontheeffectoftelmisartanramiprilon24hbloodpressureprofiledippingpatternintype1diabetespatientswithnephropathy